Worth reading
—
Scored from 0 of 6 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
14
daysWording
Avoiding a definitive answer
How definitive the wording is.Results for this period
| Item | Details |
|---|
Items this document does not state (38)
Fiscal Period ClassificationAccounting standardsConsolidated / non-consolidatedPeriod CoveredNet SalesOperating profitOrdinary incomeProfit attributable to owners of the parentNet income per shareOperating MarginEquity ratioTotal assetsNet assetsCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodFull-year earnings forecastRevision to Earnings ForecastAnnual Dividend ForecastPayout ratioShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogDepreciation and amortizationImpairment lossBreakdown of extraordinary income (loss)Disclosure regarding the going concern assumptionChange in accounting policyChanges in the scope of consolidationMaterial subsequent eventsAvailability of Supplementary Financial Results MaterialsAvailability of Financial Results BriefingIssued Shares at Period-EndTreasury Shares at Period-EndFactors Behind Changes in Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.More time is required to finalize the financial results. In light of the rapid changes in the business environment, the company is reviewing its supply plan for its oncology product portfolio and products under development, and requires additional consideration of the amount to be recorded as a provision for loss compensation related to contracts with contract manufacturers. The company also determined that explaining the Medium-Term Management Plan on the same day as the financial results would be appropriate for investment decisions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.